• To provide to infectious disease specialists, clinical microbiologists, intensive care physicians, emergency department physicians and paediatricians an updated overview of all aspects of sepsis, from pathophysiology to management.
• To give participants the opportunity to have state-of-the-art, new insights and scientific exchanges on sepsis diagnosis and treatment, including:
· Current views on the pathogenesis of sepsis
· Usefulness of biomarkers in sepsis
· New developments in the diagnosis of sepsis
· The new “Surviving Sepsis Guidelines” update
· Novel antibiotics and optimal dosing in sepsis
· Novel adjunctive immunotherapies
· The sepsis research agenda for the coming decade
• To give participants the opportunity to have small scale insightful discussions with the leaders in the field.
30 – 50 graduate and postgraduate students, infectious diseases specialists, clinical microbiologists, intensive care doctors and other specialties interested in all aspects of sepsis.
Matteo Bassetti, Udine, Italy
Thierry Calandra, Lausanne, Switzerland
Winfried V. Kern, Freiburg, Germany
Jordi Rello, Barcelona, Spain
Willem Joost Wiersinga, Amsterdam, Netherlands
ESCMID PK/PD of Anti-Infectives Study Group - EPASG
ESCMID Study Group for Bloodstream Infections and Sepsis - ESGBIS
ESCMID Study Group for Infections in Critically Ill Patients - ESGCIP
European Sepsis Academy
The organizers of the course will apply for European CME accreditation through EACCME.

Speakers


Matteo Bassetti, Udine, Italy
Stijn I. Blot, Ghent, Belgium
Marc J.M. Bonten, Utrecht, Netherlands
Thierry Calandra, Lausanne, Switzerland
Evelien de Jong, Amsterdam, Netherlands
Christian Eckmann, Hannover, Germany
Miquel Ekkelenkamp, Utrecht, Netherlands
Evangelos Giamarellos-Bourboulis, Athens, Greece
Jesus Gonzales, Madrid, Spain
Marcel Levi, Amsterdam, Netherlands
Johan Willem Mouton, Rotterdam, Netherlands
Kavi M. Ramjeet, La Balme-les-Grottes, France
Jordi Rello, Barcelona, Spain
Thierry Roger, Epalinges, Switzerland
Christopher Seymour, Pittsburgh, PA, United States
Mervyn Singer, London, United Kingdom
Jean-Francois Timsit, Paris, France
Tom van der Poll, Amsterdam, Netherlands
Willem Joost Wiersinga, Amsterdam, Netherlands

Contact Person (Scientific Programme)

Willem Joost Wiersinga
Academic Medical Center, University of Amsterdam
Division of Infectious Diseases, Center for Experimental Molecular Medicine
Meibergdreef 9
Room G2-130
1105 AZ Amsterdam
Netherlands
+31 20 566 9111
+31 20 697 7192
w.j.wiersinga@amc.uva.nl

Administrative Secretariat

Laurian Jongejan
Academic Medical Center, University of Amsterdam
Division of Infectious Diseases, Center for Experimental Molecular Medicine
Meibergdreef 9
Room KO-130
1105 AZ Amsterdam
Netherlands
+31 20 566 6819
+31 20 697 7192
l.zuidmeer@amc.uva.nl

Venue Info

Event Map
Venue Details
de Rode Hoed
Keizersgracht 102, 1015 CV Amsterdam
Netherlands
Phone: +31 20 638 5606
Fax: +31 20 625 4452
Email: info@rodehoed.nl

Course Programme



  1. 13:30 - 14:00
    Presentation
    Opening comments and learning objectives
    Speaker(s): Willem Joost Wiersinga



  2. 14:30 - 16:30
    Session
    The burden of sepsis
    Chairperson(s): Mervyn Singer



  3. 14:30 - 15:00
    Presentation
    What is sepsis? New definitions
    Speaker(s): Mervyn Singer



  4. 15:00 - 15:30
    Presentation
    The epidemiology of sepsis
    Speaker(s): Evangelos Giamarellos-Bourboulis



  5. 15:30 - 16:00
    Presentation
    The emergence of bloodstream infections due to multidrug-resistant Enterobacteriaceae


  6. 16:00 - 16:30
    Presentation
    Round table discussion with speakers
    Chairperson(s): Thierry Calandra, Jordi Rello, Tom van der Poll, Willem Joost Wiersinga



  7. 16:30 - 17:00
    Break
    Tea break


  8. 17:00 - 19:00
    Session
    The pathogenesis of sepsis
    Chairperson(s): Tom van der Poll



  9. 17:00 - 17:30
    Presentation
    The host response in sepsis
    Speaker(s): Tom van der Poll



  10. 17:30 - 18:00
    Presentation
    What makes the host susceptible to sepsis?
    Speaker(s): Thierry Roger



  11. 18:00 - 18:30
    Presentation
    The coagulation system in sepsis
    Speaker(s): Marcel Levi



  12. 18:30 - 19:00
    Presentation
    The new "Surviving Sepsis Campaign" guidelines 2017: a summary
    Speaker(s): Mervyn Singer



  13. 19:00 - 22:00
    Social Activity
    Drinks and dinner at restaurant Lieve, Amsterdam


  1. 08:30 - 10:30
    Session
    Diagnosis of sepsis
    Chairperson(s): Willem Joost Wiersinga



  2. 08:30 - 09:00
    Presentation
    Novel developments in rapid bedside tests for pathogen detection
    Speaker(s): Kavi M. Ramjeet



  3. 09:00 - 09:30
    Presentation
    Biomarkers in sepsis: an overview
    Speaker(s): Tom van der Poll



  4. 09:30 - 10:00
    Presentation
    The pro’s and con’s of the use of procalcitonin in sepsis
    Speaker(s): Evelien de Jong



  5. 10:00 - 10:30
    Presentation
    A teaser for the next session: difficult cases in sepsis management
    Speaker(s): Christopher Seymour



  6. 10:30 - 11:00
    Break
    Coffee Break


  7. 11:00 - 13:00
    Session
    Management of sepsis part I (basic principles)
    Chairperson(s): Jordi Rello



  8. 11:00 - 11:30
    Presentation
    Antibiotic therapy for sepsis: the basics
    Speaker(s): Miquel Ekkelenkamp



  9. 11:30 - 12:00
    Presentation
    Optimal antibiotic dosing strategies in sepsis
    Speaker(s): Johan Willem Mouton



  10. 12:00 - 12:30
    Presentation
    Adjunctive immunotherapies for patients with sepsis: it is time for personalized medicine
    Speaker(s): Jordi Rello



  11. 12:30 - 13:00
    Presentation
    The gut microbiota in sepsis
    Speaker(s): Willem Joost Wiersinga



  12. 13:00 - 14:00
    Lunch
    Lunch


  13. 14:00 - 15:30
    Session
    Management of sepsis part II (organ- and host-specific)
    Chairperson(s): Christian Eckmann



  14. 14:00 - 14:30
    Presentation
    Novel antibiotics for sepsis
    Speaker(s): Miquel Ekkelenkamp



  15. 14:30 - 15:00
    Presentation
    Source control in intra-abdominal sepsis
    Speaker(s): Christian Eckmann



  16. 15:00 - 15:30
    Presentation
    Novel trial design in sepsis
    Speaker(s): Christopher Seymour



  17. 15:30 - 22:00
    Social Activity
    Social event: sepsis sailing surprise including drinks and dinner (Ijsselmeer)


  1. 09:30 - 11:30
    Session
    Management of sepsis part III (pathogen-specific)
    Chairperson(s): Matteo Bassetti



  2. 09:30 - 10:00
    Presentation
    Sepsis and the challenges in antimicrobial resistance
    Speaker(s): Marc J.M. Bonten



  3. 10:00 - 10:30
    Presentation
    Empiric and definitive antifungal therapy in sepsis
    Speaker(s): Matteo Bassetti



  4. 10:30 - 11:00
    Presentation
    De-escalation in sepsis
    Speaker(s): Jean-Francois Timsit



  5. 11:00 - 11:30
    Break
    Tea break


  6. 11:30 - 13:30
    Session
    The road ahead
    Chairperson(s): Marc J.M. Bonten



  7. 11:30 - 12:00
    Presentation
    Stem cell treatment strategies in sepsis
    Speaker(s): Jesus Gonzales



  8. 12:00 - 12:30
    Presentation
    The actual and future role of the nurse in the management of sepsis
    Speaker(s): Stijn I. Blot



  9. 12:30 - 13:00
    Presentation
    The road ahead: key question in sepsis research (representatives of the European Sepsis Academy)


  10. 13:00 - 13:30
    Presentation
    Round table discussion and closure
    Chairperson(s): Matteo Bassetti, Jordi Rello, Tom van der Poll, Willem Joost Wiersinga


01-May-2017
550
600
The registration fee includes lunches, tea/coffee breaks, dinner, teaching materials and social activities. Travel and accommodation are not included. Numerous choices of accommodation in all price ranges are available in the immediate vicinity of the course venue.
01-Apr-2017
17-Apr-2017